Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 15/20 | 0.48 |
| ▸ | NPY1R | P25929 | 8/20 | 0.48 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.48 |
| ▸ | NPY2R | P49146 | 5/20 | 0.48 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.43 |
| ▸ | ACE | P12821 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1662044 | 0.89 | NPY4R (0.38) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL12793611 | 0.88 | NPY4R (0.60) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL19252747 | 0.86 | PTGER4 (0.45) | NPY4RNPY1RNPY5RNPY2RACE | |
| SCHEMBL1661320 | 0.83 | GRIA1 (0.43) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL1661328 | 0.81 | NPY4R (0.37) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL17495217 | 0.81 | NPY4R (0.42) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL12793435 | 0.80 | NPY4R (0.49) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL16728107 | 0.80 | NPY4R (0.69) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL1661928 | 0.79 | CTSL (0.47) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL1661229 | 0.78 | ACE (0.51) | ACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011048390-A2 | GADD45BETA TARGETING AGENTS | IMPERIAL INNOVATIONS LIMITED (GB) | 2011-04-28 | — | — | WO | claimed |
| WO-2011048390-A2 | GADD45BETA TARGETING AGENTS | IMPERIAL INNOVATIONS LIMITED (GB) | 2011-04-28 | — | — | WO | disclosed |